| Name | Title | Contact Details |
|---|
Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents for various diseases screening and monitoring.
Our mission at Kelyniam is to apply 3D printing and rapid prototyping technology to create innovative medical products that improve the lives of physicians and their patients.
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries.
Milestone was founded in 2005 with the underlying concept to base its drug development programs on clinically validated mechanisms of action in order to mitigate as much drug development risk as possible. The company has raised a total of $34 million in venture capital financing since 2006. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. The drug hunters proposed NCE projects based on clinically proven science to form the basis of Milestone’s drug development programs. Milestone has a seasoned management team with experience in cardiovascular diseases, drug development and business start-ups as well as world-class advisory boards of key opinion leaders with significant expertise in cardiology, regulatory affairs, as well as formulation and drug development.
Ionwerks is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.